CompletedNot Applicable

Reiki Therapy to Improve Key Symptoms in Integrative Oncology Clinic (REIKI)

United States10 participantsStarted 2024-08-07

Plain-language summary

The purpose of this research is to investigate the delivery of Reiki to integrative oncology patients and assess its potential for improving cancer-related symptoms in this population.

Who can participate

Age range18 Years – 89 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Age 18 - 89. * Neoplasm diagnosis (i.e., ICD-10 C00 - D49) confirmed in electronic health record (EHR)/Caisis * Receiving care at a UH Connor Whole Health Integrative Oncology Clinic. * Reporting at least three ESAS symptoms ≥4/10 at baseline screening including fatigue and ≥2 other symptoms on the 9-item questionnaire. * Able to speak and understand English. * Has an email address, and access to a computer with internet and/or a mobile device with a functioning data plan Exclusion Criteria: * Significant cognitive impairment that has not been corrected. * Significant visual impairment that has not been corrected. * Unable to provide informed consent. * Active psychosis. * Pregnancy. * Metastatic disease. * Reiki therapy within 3 months of study enrollment * Active immunotherapy, chemotherapy, or radiation treatment, or completed within 3 months before study start. Aromatase inhibitors and tamoxifen are exceptions.

What they're measuring

Recruitment rate as measured by the percentage of participants enrolled

Timeframe: 8 weeks post enrollment

Retention rate as measured by the number of participants retained until the final survey point

Timeframe: 8 weeks post enrollment

Attendance rate as measured by number of sessions attended per 6 sessions

Timeframe: 8 weeks post enrollment

Protocol adherence rate as measured by the number of participants treated in manner consistent with the intervention

Timeframe: 8 weeks post enrollment

Acceptability as measured by the patient mean of participant satisfaction survey

Timeframe: 8 weeks post enrollment

Data completeness rate

Timeframe: 8 weeks post enrollment

Trial details

NCT IDNCT06354049

SponsorCase Comprehensive Cancer Center

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2025-07-17

View on ClinicalTrials.gov More Cancer Pain trials

Who can participate

Age range18 Years – 89 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

What they're measuring

Recruitment rate as measured by the percentage of participants enrolled

Timeframe: 8 weeks post enrollment

Retention rate as measured by the number of participants retained until the final survey point

Timeframe: 8 weeks post enrollment

Attendance rate as measured by number of sessions attended per 6 sessions

Timeframe: 8 weeks post enrollment

Protocol adherence rate as measured by the number of participants treated in manner consistent with the intervention

Timeframe: 8 weeks post enrollment

Acceptability as measured by the patient mean of participant satisfaction survey

Timeframe: 8 weeks post enrollment

Data completeness rate

Timeframe: 8 weeks post enrollment